NCT04702672Completed
High-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 Diabetes
High-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 Diabetes: a Randomized, Cross-over, Acute Dietary Intervention Study.
Source: ClinicalTrials.gov · Last updated 14 Nov 2024
Brief summary (registry, in English)
In a series of double-blinded randomized cross-over acute studies, the investigators want to study the effects of naturally produced high-amylose barley (Lean-baking barley®) on the postprandial glucose-metabolism in subjects with and without type 2 diabetes (T2D).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 38 (actual)
- First submitted
- 9 Dec 2020
- Start date
- 1 Jan 2023
- Primary completion date
- 1 Jul 2024
- Lead sponsor
- University of Aarhus
- Diseases
- Type 2 diabetes
- NCT number
- NCT04702672
What you commit to
- Study type: Interventional
- Participants enrolled: 38
- From 1 Jan 2023 to the primary completion date, 1 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment with steroids
- Alcohol or drug abuse
Other illness
- Type 1 diabetes
- Significant psychiatric history
Other
- Insulin demanding T2D
- Use of weekly administrated GLP-1 antagonist (e.g. ozempic, trulicity or byetta)
- Use of acarbose
- Significant cardiovascular, kidney, liver or endocrine comorbidity
- Pregnancy or breastfeeding
- Legally incompetent
Who the study is looking for
- T2D defined by standard Danish guidelines.
- HbA1c between 42-78 mmol/l.
- Treatment with drugs for hypertension and high cholesterol is allowed if the treatment dose is stable and does not demand changes during the study period.
- Participants are encouraged to maintain their present psychical activity level and their smoking and alcohol habits.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aarhus University Hospital Coordinator of this site? Confirm its status | Aarhus | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.